NTCOC
ACOR

Northern Trust Company of Connecticut’s Acorda Therapeutics ACOR Stock Holding History

Northern Trust Company of Connecticut’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$470K Sell
134
-2
-1% -$7.8K ﹤0.01% 1582
2013
Q3 		$557K Buy
136
+8
+6% +$34.5K ﹤0.01% 1500
2013
Q2 		$508K Buy
+128
New +$527K ﹤0.01% 1482

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Company of Connecticut's ACOR Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its Acorda Therapeutics (ACOR) stake by 1.5% in Q4 2013, selling an estimated $7.8K and leaving 134 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #1582.

Northern Trust Company of Connecticut first reported a position in ACOR in Q2 2013 and has held it in 3 quarters since. The position peaked at $557K in Q3 2013. 163 funds tracked by Wall St. Rank hold ACOR as of Q4 2013.

  • Northern Trust Company of Connecticut held 134 shares of Acorda Therapeutics worth $470K as of Q4 2013.
  • Northern Trust Company of Connecticut sold 2 Acorda Therapeutics shares in Q4 2013, an estimated $7.8K.
  • Acorda Therapeutics made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1582 holding.
  • Northern Trust Company of Connecticut first reported a position in Acorda Therapeutics in Q2 2013 and has held it in 3 quarters since.
  • Northern Trust Company of Connecticut's Acorda Therapeutics position peaked at $557K in Q3 2013.
  • 163 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.